Sunday, November 22, 2026

Tag: Emcure

Browse our exclusive articles!

Emcure Pharma’s Gujarat plant gets all-clear from US FDA

Emcure Pharmaceuticals Ltd on Tuesday, December 23, said it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration...

Emcure Pharma launches semaglutide-based weight management drug Poviztra in India

Emcure Pharmaceuticals Ltd. has launched Poviztra, a semaglutide injection for chronic weight management, marking its entry into the fast-growing obesity and metabolic health segment,...

Stocks to Watch: Paytm, Emcure Pharma, JSW Energy, HCLTech and more

1 / 11Paytm | A 2% stake in the company is likely to be sold through a block deal by SAIF III Mauritius,...

Emcure shares jump 8% on Novo Nordisk tie-up to launch weight-loss drug in India

Novo Nordisk India has entered into a strategic partnership with Emcure Pharmaceuticals to launch Poviztra®, the second brand of Wegovy® (semaglutide injection 2.4 mg),...

Emcure Pharma to distribute Sanofi’s oral anti-diabetic drugs across India

Emcure Pharmaceuticals Ltd and Sanofi India Ltd have announced a distribution and promotion partnership on Wednesday (July 16) aimed at expanding access to Sanofi’s oral anti-diabetic...

Popular

‘Trump has cost us’: After midterm losses, MAGA asks if it’s over

As Republicans faced a nationwide drubbing in Tuesday’s midterm...

Prashant Jain sees 12-15% annual returns from Indian equities over 3-5 years

Question We've had a very painful period for the equity...

Raamdeo Agrawal sees FIIs return as earnings improve and valuations turn attractive

Question Looking at the valuation compression across the market, are...

Stocks to Watch for November 2: Reliance Industries, Jio Platforms, BEL, Vodafone Idea, IOC, M&M and more

From Reliance Industries and Jio Platforms reporting strong quarterly...

Subscribe

spot_imgspot_img